Difference between revisions of "Template:New Product"
From Bioblast
Beno Marija (talk | contribs) |
Beno Marija (talk | contribs) |
||
| Line 5: | Line 5: | ||
</div> | </div> | ||
<div style="background-color:#ffffff;padding-top:0.2em;padding-right: 0.4em;padding-bottom: 0.2em;padding-left: 0.4em;"> | <div style="background-color:#ffffff;padding-top:0.2em;padding-right: 0.4em;padding-bottom: 0.2em;padding-left: 0.4em;"> | ||
[[File:MITOKIT-CII.jpg|right| | [[File:MITOKIT-CII.jpg|right|200px|MitoKit-CII|link=https://wiki.oroboros.at/index.php/MitoKit-CII]] | ||
:The cell permeable compounds '''MitoKit-CII''', including succinate-nv and malonate-nv, are the first generation of [[NeuroVive|NeuroVive Pharmaceutical AB's]] prodrugs and have been developed to stimulate or inhibit Complex II of the respiratory electron transfer system in living cells. The MitoKit-CII will expand the toolbox for evaluating the role of mitochondria in disease. | :The cell permeable compounds '''MitoKit-CII''', including succinate-nv and malonate-nv, are the first generation of [[NeuroVive|NeuroVive Pharmaceutical AB's]] prodrugs and have been developed to stimulate or inhibit Complex II of the respiratory electron transfer system in living cells. The MitoKit-CII will expand the toolbox for evaluating the role of mitochondria in disease. | ||
Revision as of 15:27, 11 July 2019
- The new MitoKit-CII
- The cell permeable compounds MitoKit-CII, including succinate-nv and malonate-nv, are the first generation of NeuroVive Pharmaceutical AB's prodrugs and have been developed to stimulate or inhibit Complex II of the respiratory electron transfer system in living cells. The MitoKit-CII will expand the toolbox for evaluating the role of mitochondria in disease.
- » For more information: wiki.oroboros.at/index.php/MitoKit-CII
- » For offers refer to: instruments@oroboros.at
